Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-750
Closed -$36.3K 528
2025
Q4
$36.3K Hold
750
﹤0.01% 391
2025
Q3
$35.4K Hold
750
﹤0.01% 385
2025
Q2
$36.2K Hold
750
﹤0.01% 393
2025
Q1
$41.6K Hold
750
﹤0.01% 362
2024
Q4
$36.2K Hold
750
﹤0.01% 366
2024
Q3
$43.2K Hold
750
﹤0.01% 334
2024
Q2
$36.4K Sell
750
-210
-22% -$10.1K ﹤0.01% 349
2024
Q1
$46.7K Buy
960
+210
+28% +$10.3K ﹤0.01% 310
2023
Q4
$37.3K Buy
+750
New +$36.7K ﹤0.01% 324

Other funds holding SNY

TCTC Holdings's SNY Position: Q1 2026 in Review

TCTC Holdings sold out of Sanofi (SNY) in Q1 2026, closing a stake of 750 shares — an estimated $36.3K sold.

TCTC Holdings first reported a position in SNY in Q4 2023 and held it in 9 quarters. The position peaked at $46.7K in Q1 2024. 745 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

  • TCTC Holdings reported no remaining Sanofi position as of Q1 2026 after selling out during the quarter.
  • TCTC Holdings sold 750 Sanofi shares in Q1 2026, an estimated $36.3K.
  • TCTC Holdings first reported a position in Sanofi in Q4 2023 and held it in 9 quarters.
  • TCTC Holdings's Sanofi position peaked at $46.7K in Q1 2024.
  • 745 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on TCTC Holdings's 13F filing for Q1 2026, filed 7 May 2026.